Date(s) - Tuesday, July 21, 2015, 12:00 PM - 1:30 PM
Add to Calendar
iCalendar - iCal
Google Calendar -
- Learn about the specifics of the cancer care payment programs being implemented by UnitedHealthcare and Anthem, Inc.
- Hear about the expectations, outcomes, and results of these programs related to cost control
- Discover the impact of these programs on consumers
This webinar will feature presentations by two health plans on the use of innovative payment approaches for cancer care. UnitedHealthcare has launched a pilot to explore a head and neck cancer care payment model that focuses on quality patient care and outcomes. Anthem, Inc. has turned to the use of pathways, which provide certain treatment options and provider payment arrangements. What are the outcomes of these programs? And what is the impact on consumers? We’ll hear a reaction from the National Coalition for Cancer Survivorship.
- Welcome and Opening Remarks – Anne Gauthier, Mark Smith
- Guiding Committee Updates – Mark Smith
- Sharing of UnitedHealthcare’s Cancer Care Payment Model – Lee N. Newcomer
- Sharing of Anthem’s Cancer Care Payment Model – Jennifer Malin
- Reaction from a Consumer’s Perspective – Shelley Fuld Nasso
- Questions from LAN Participants – Anne Gauthier
- Closing Comments and Upcoming LAN Activities – Anne Gauthier, Mark Smith
Several experts attended the recent LAN webinar panel that took place on July 21, 2015. Lee Newcomer of UnitedHealthcare and Jennifer Malin of Anthem, Inc. each discussed how their organizations’ innovative approaches to cancer care pathway options and episode payments have positively impacted patient health outcomes and consumer spending. Shelley Fuld Nasso of the National Coalition for Cancer Survivorship emphasized that the Centers for Medicare & Medicaid Services (CMS) and other payers should implement innovative payment models that encourage provider-patient cancer care discussions, and also shared core principles of patient-centered payment reform that included protections against both patient under-utilization and over-utilization. The panel addressed questions such as how the described episode payment models apply to pediatric populations, the financial impacts of the payment models in terms of cost savings, and how the episode payments affect pharmacy benefits, and whether additional studies should occur across other specialties to determine if the described episode payments could be successful.